Terminated OBSERVATIONAL NCT00568009

Study to Evaluate the Effect of SLV320 in Addition to Chronic Furosemide Treatment on Renal Function in Subjects With Congestive Heart Failure and Impaired Renal Function

Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Sequential Cohort Study to Evaluate the Effect of SLV320 in Addition to Chronic Furosemide Treatment on Renal Function in Subjects With Congestive Heart Failure and Impaired Renal Function

Sponsor: Quintiles, Inc.

Conditions Congestive Heart Failure

Interventions SLV320

Updated 12 times since 2017 Last updated: Apr 18, 2008 Started: Oct 31, 2007 Primary completion: Nov 30, 2008 Completion: Nov 30, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

additional enrolment criteria made patients' recruitment not feasible anymore

Other terminated trials from Quintiles, Inc.

More terminations from Quintiles, Inc.

Other Congestive Heart Failure trials with similar outcome

Browse all Congestive Heart Failure trials

A observational or N/A phase clinical study on Congestive Heart Failure, this trial is terminated or withdrawn. The trial is conducted by Quintiles, Inc. and has accumulated 12 data snapshots since 2007. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

12 versions recorded

Sep 2025 — Present [monthly]

Terminated
Sep 2024 — Sep 2025 [monthly]

Terminated
Jul 2024 — Sep 2024 [monthly]

Terminated
Dec 2021 — Jul 2024 [monthly]

Terminated
Jan 2021 — Dec 2021 [monthly]

Terminated

▶ Show 7 earlier versions

Nov 2020 — Jan 2021 [monthly]

Terminated
Jun 2018 — Nov 2020 [monthly]

Terminated
May 2018 — Jun 2018 [monthly]

Terminated
Apr 2018 — May 2018 [monthly]

Terminated

Phase: NA → None
Aug 2017 — Apr 2018 [monthly]

Terminated NA
Feb 2017 — Aug 2017 [monthly]

Terminated NA
Jan 2017 — Feb 2017 [monthly]

Terminated NA

First recorded

Oct 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Quintiles, Inc.
Solvay Pharmaceuticals

Data source: Solvay Pharmaceuticals

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Antwerp, Belgium , Atlanta, United States , Bad Nauheim, Germany , Bahía Blanca, Argentina , Barcelona, Spain , Belgrade, Serbia and Montenegro , Belville, South Africa , Berlin, Germany , Bloemfontein, South Africa , Brno, Czechia and 49 more locations